Axxion S.A.’s BioNTech BNTX Stock Holding History

Axxion S.A.’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$451K	Buy	+5,500	New	+$518K	0.03%	235

Other funds holding BNTX

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Axxion S.A.'s BNTX Position: Q2 2026 in Review

Axxion S.A. opened a new position in BioNTech (BNTX) in Q2 2026: 5,500 shares worth $451K. The stake represents 0.03% of the portfolio and ranks #235 among its holdings.

262 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Axxion S.A. held 5,500 shares of BioNTech worth $451K as of Q2 2026.
BioNTech was a new Axxion S.A. position in Q2 2026.
BioNTech made up 0.03% of Axxion S.A.'s portfolio in Q2 2026, its #235 holding.
262 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Axxion S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.